Parcell Laboratories

Parcell Laboratories, the research arm of the Parcell Group of biotechnology companies, was founded in 2008 explicitly to explore the potential applications of a newly discovered line of stem cells called early lineage adult (ELA) stem cells. Headed by Pamela Layton and based in Natick, Massachusetts, Parcell Laboratories partners with Harvard-based researchers in regenerative medicine to identify optimal therapeutic areas for the ELA line. Positive study results in spinal surgery patients continue to spur product development and business affiliations with biotechnology storage and distribution companies. Future goals include expansion of allogeneic ELA capabilities in broad therapeutic areas beyond joint and spinal treatment.